NAV
19.87(-0.30%)Fund Size (CR)
₹854.04Expense Ratio
2.3Scheme Type
Active FundValue Research
-
Min. investment
₹1,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹10Minimum Withdrawal
₹1Exit Load
1%Return Since Launch
17.96%
Basic Details
Scheme Manager
Dhaval Shah
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | March 25, 2026 | 9788.17 | -2.12% | - | -2.10% | 557/1007 |
| 1 Month | February 27, 2026 | 9636.27 | -3.64% | - | -8.62% | 18/987 |
| 3 Month | January 1, 2026 | 9795.70 | -2.04% | - | -10.46% | 51/964 |
| 6 Month | October 1, 2025 | 9823.02 | -1.77% | - | -7.72% | 92/920 |
| 1 Year | April 1, 2025 | 10382.94 | 3.83% | 3.83% | 2.62% | 296/860 |
| 3 Year | March 31, 2023 | 18669.46 | 86.69% | 23.09% | 16.52% | 79/518 |
| 5 Year | April 1, 2021 | 18840.51 | 88.41% | 13.50% | 14.07% | 215/430 |
| Since Inception | July 11, 2019 | 30386.27 | 203.86% | 17.96% | 6.89% | 90/1007 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | April 1, 2025 | 1,30,000 | 187674.81 | 44.37% | 44.37% |
| 3 Year | April 3, 2023 | 3,70,000 | 589842.03 | 59.42% | 16.82% |
| 5 Year | April 1, 2021 | 6,10,000 | 1072816.91 | 75.87% | 11.95% |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.57%
Standard Deviation
0.85%
Beta
1.17%
Sharpe Ratio
0.05%
Treynor's Ratio
13.28%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 13.34% | 656076 | 113.96 | Equity | Pharmaceuticals |
| Apollo Hospitals | 7.78% | 84936 | 66.43 | Equity | Healthcare |
| Torrent Pharma. | 5.20% | 102446 | 44.39 | Equity | Pharmaceuticals |
| J B Chemicals & | 4.99% | 207484 | 42.61 | Equity | Pharmaceuticals |
| Ajanta Pharma | 4.53% | 129312 | 38.71 | Equity | Pharmaceuticals |
| Lupin | 4.21% | 156214 | 35.96 | Equity | Pharmaceuticals |
| Fortis Health. | 4.17% | 377564 | 35.59 | Equity | Healthcare |
| Aurobindo Pharma | 4.16% | 291254 | 35.54 | Equity | Pharmaceuticals |
| Abbott India | 4.02% | 12933 | 34.31 | Equity | Pharmaceuticals |
| Ipca Labs. | 3.94% | 220197 | 33.67 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct (G) | 519.50 | 13.71% | 42.79% | 58.21% | 169.02% | 50.25% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 519.50 | 13.71% | 42.79% | 58.21% | 169.02% | 50.25% | |
| Nippon India Japan Equity Fund - Direct (G) | 311.26 | -4.31% | 10.93% | 13.63% | 36.88% | 18.95% | |
| Nippon India Japan Equity Fund - Direct (Bonus) | 311.26 | -4.31% | 10.93% | 13.63% | 36.88% | 18.95% | |
| Nippon India Japan Equity Fund - Direct (IDCW) | 311.26 | -4.31% | 10.93% | 13.63% | 36.88% | 18.95% |
List of Schemes under Aditya Birla Sun Life Mutual Fund
News
Aditya Birla Sun Life Mutual Fund announces change in fund manager under its schemes
Aditya Birla Sun Life Mutual Fund has announced change in fund manager under the following schemes, With effect from 02 April 2026.Change in Fund Manager:
Scheme Name Existing Fund Managers New Fund Managers Aditya Birla Sun Life Equity Savings Fund Mr. Lovelish Solanki, Mr. Atul Penkar and
Mr. Harshil Suvarnkar
Mr. Lovelish Solanki, Mr. Atul Penkar,
Mr. Harshil Suvarnkar and
Mr. Rohit Karan
Aditya Birla Sun Life Balanced Advantage Fund Mr. Harish Krishnan, Mr. Lovelish Solanki and
Mr. Mohit Sharma
Mr. Harish Krishnan, Mr. Lovelish Solanki.
Mr. Mohit Sharma and
Mr. Rohit Karan
Aditya Birla Sun Life Mutual Fund announces Appointment of Key Personnel
Aditya Birla Sun Life Mutual Fund has announced that Mr. Manish Gupta has been appointed as Senior Fund Manager ' Equity with effect from March 20, 2026 ('Effective Date').Details of Mr. Manish Gupta
Age: 45 years
Designation: Senior Fund Manager ' Equity
Qualification: Post Graduate Diploma in Management ' IIM Indore .
Powered by Capital Market - Live News
Aditya Birla Sun Life MF announces Income Distribution cum Capital Withdrawal (IDCW) under its schemes
Aditya Birla Sun Life Mutual Fund has announced 27 March 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) under the following schemes. The quantum of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Aditya Birla Sun Life Balanced Advantage Fund:
Regular Plan ' IDCW Option: 0.145
Direct Plan ' IDCW Option: 0.167
Aditya Birla Sun Life Arbitrage Fund:
Regular Plan ' IDCW Option: 0.065
Direct Plan ' IDCW Option: 0.067
Aditya Birla Sun Life Dividend Yield Fund:
Regular Plan ' IDCW Option: 0.370
Direct Plan ' IDCW Option: 0.675
Aditya Birla Sun Life Equity Hybrid '95 Fund:
Regular Plan ' IDCW Option: 2.846
Direct Plan ' IDCW Option: 4.887
Aditya Birla Sun Life Equity Savings Fund Fund:
Regular Plan ' IDCW Option: 0.230
Direct Plan ' IDCW Option: 0.271
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
June 20, 2019
Total AUM (Cr)
₹854.04
Aditya Birla SL Pharma & Healthcare Fund (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, Aditya Birla Sun Life Mutual Fund. Launched in June 20, 2019, this fund is managed by Dhaval Shah. With assets under management (AUM) worth ₹854.04 (Cr), as of April 1, 2026, Aditya Birla SL Pharma & Healthcare Fund (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 17.96% since its launch.
The current NAV of Aditya Birla SL Pharma & Healthcare Fund (IDCW) is ₹19.87, as on April 1, 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in Aditya Birla SL Pharma & Healthcare Fund (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹10 while the minimum lumpsum investment is ₹1,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 23.09% and 13.50% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.45% in Equity, 1.57% in Debt and -0.01% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 76.15% in Pharmaceuticals & Biotech, 19.65% in Healthcare Services, 2.24% in Debt, 1.28% in Insurance, 0.89% in Chemicals & Petrochemical
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors
